Related Experiment Video
Updated: Aug 3, 2026

Genetically-encoded Molecular Probes to Study G Protein-coupled Receptors
Published on: September 13, 2013
Small Molecule Fluorescent Ligands for the Atypical Chemokine Receptor 3 (ACKR3)
Sebastian Dekkers1, Dehan Comez2,3, Noemi Karsai2,3
1Biodiscovery Institute, School of Pharmacy, University of Nottingham, Nottingham NG7 2RD, United Kingdom.
Researchers developed novel fluorescent probes targeting the atypical chemokine receptor 3 (ACKR3), a key driver of cancer progression. These probes enable detailed study of ACKR3
Area of Science:
- Chemical Biology
- Oncology
- Molecular Imaging
Background:
- The atypical chemokine receptor 3 (ACKR3) is implicated in cancer progression and metastasis across various cell types.
- There is a critical need for advanced chemical tools to investigate the role of ACKR3 in oncogenesis and disease pathology.
Purpose of the Study:
- To synthesize and characterize novel fluorescent probes for studying the atypical chemokine receptor 3 (ACKR3).
- To evaluate the utility of these probes in investigating ACKR3's function in cellular contexts.
Main Methods:
- Synthesis of a series of small molecule ACKR3 agonists.
- Development of fluorescent probes based on these agonists.
- Characterization using luminescence-based NanoBRET binding assays and confocal microscopy.
Main Results:
- Three fluorescent probes demonstrated specific binding to ACKR3 with high affinity (pKd 6.8–7.8).
- Probes were successfully applied in competition binding experiments.
- Cellular distribution of ACKR3 was visualized using confocal microscopy.
Conclusions:
- Novel fluorescent probes targeting ACKR3 have been successfully developed.
- These probes serve as valuable chemical tools for investigating ACKR3's role in cancer and other diseases.
- The probes facilitate cellular localization studies and binding assays, advancing research in chemokine receptor biology.
More Related Videos
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
06:56A Flow Cytometry-based Assay to Identify Compounds That Disrupt Binding of Fluorescently-labeled CXC Chemokine Ligand 12 to CXC Chemokine Receptor 4
Published on: March 10, 2018